Pregnancy loss, recurrent, susceptibility to, 1
MONDO:0013727Any pregnancy loss, recurrent, susceptibility in which the cause of the disease is a mutation in the F5 gene.
Also known as: F5 pregnancy loss, recurrent, susceptibility, pregnancy loss, recurrent, susceptibility caused by mutation in F5, pregnancy loss, recurrent, susceptibility to, 1, pregnancy loss, recurrent, susceptibility to, type 1, RPRGL1, Rpl, Rprgl, abortion, spontaneous, recurrent
11 clinical trials for this condition and its sub-types, 11 tagged with Pregnancy loss, recurrent, susceptibility to, 1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a common drug make abortion safer? new trial aims to find out
Disease control Recruiting nowThis study tests whether giving tranexamic acid (TXA) before a second-trimester dilation and evacuation (D&E) procedure can reduce heavy bleeding. Heavy bleeding is a rare but serious risk of D&E. The trial will include 276 pregnant people aged 18 and older who are between 18 and…
Phase 4 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
One pill to stop breast pain after pregnancy loss? new trial tests cabergoline
Symptom relief Recruiting nowThis phase 2 trial tests whether a single dose of cabergoline can prevent breast engorgement, milk leakage, and tenderness after abortion or pregnancy loss at 12-18 weeks. About 348 participants will receive either cabergoline or a placebo right after the procedure and report sym…
Phase 2 • Sponsor: Jefferson Drapkin • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a common allergy drug ease abortion pain?
Symptom relief Recruiting nowThis study tests whether adding diphenhydramine (an antihistamine) to standard sedation medicine reduces pain during first-trimester abortion. About 98 adults will receive either diphenhydramine or a placebo alongside usual care. The goal is to see if this simple addition improve…
Phase 4 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New combo injection aims to ease abortion pain
Symptom relief Recruiting nowThis study tests whether a paracervical block (an injection near the cervix) containing ketorolac and lidocaine can reduce pain during placement of osmotic dilators, which are used to prepare the cervix for a second-trimester abortion. About 76 participants will be randomly assig…
Phase 2 • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Could low egg count predict miscarriage? new study seeks answers
Knowledge-focused Recruiting nowThis study is looking at whether women with lower ovarian reserve (fewer eggs) have had more early miscarriages in the past. Researchers will measure ovarian reserve with a blood test (AMH) and an ultrasound (antral follicle count) in over 2,000 women seeking fertility care. This…
Sponsor: ART Fertility Clinics LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
20,000 women join study to uncover Abortion's impact on later pregnancies
Knowledge-focused Recruiting nowThis study is following 20,000 women in China who had an induced abortion early in pregnancy (before 12 weeks). Researchers want to see if having an abortion in the past leads to more complications or problems in later pregnancies. The women will be tracked over time to compare t…
Sponsor: National Research Institute for Family Planning, China • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:16 UTC